Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

OvaScience Slashes Workforce, Replaces CEO

OvaScience named a new chief executive officer and slashed its employee count by half.

Read More »

Publicis Health appoints Brion Brandes, EVP, Business Development

Publicis Health’s message delivery businesses announced that Brion Brandes has been named Executive Vice President of Business Development.

Read More »

Purohit Navigation expands staffing capabilities with key hires

Purohit Navigation – a full-service, independent, healthcare communications and advertising agency – announced that the company has expanded its already seasoned staff to serve a growing client base.

Read More »

Bayer appoints new leader for U.S. Oncology business

Bhavesh Ashar was tapped as senior VP and head of Oncology for Bayer’s Pharmaceuticals Division in the United States. Ashar reports to Carsten Brunn, head of Bayer Pharmaceuticals for the Americas region.

Read More »

New president for Astellas US Technologies

John DeMay has been appointed president, Astellas US Technologies Inc. (AUST).

Read More »

New CEO and chairman for Vencerx

Robert H. Ring, Ph.D., was appointed CEO and Jeffrey Stevenson was made chairman of the board of directors for Vencerx Therapeutics.

Read More »

New chief commercial officer at Grünenthal

Mark Fladrich has taken over the position of chief commercial officer at the Grünenthal Group and now is responsible for the entire global commercial organization.

Read More »

Valeant makes key appointments in dermatology, corporate communications

Michael McMyne joined Valeant Pharmaceuticals International Inc.’s dermatology division as VP of sales, and Stacey Williams joined as VP of marketing. Additionally, the company announced Lainie Keller joined as VP of corporate communications.

Read More »

People on the Move: Biotechnology Companies

Daniel Menichella is appointed CEO of CureVac Inc., the Boston-based U.S. subsidiary of CureVac AG.

Read More »

People on the Move: Specialty Pharma Companies

Paul M. Bisaro was made president and CEO as well as a member of the board of directors of Impax Laboratories Inc.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom